Anti-ageing Medicine: Myths and Chancesvdf Hochschulverlag AG, 2008 - 304 páginas The 21st century technological development is revolutionizing medicine and health care, bringing new hopes to human suffering by offering cures and treatments which were unthinkable a few decades ago. This is where anti-ageing medicine finds its niche. Anti-ageing medicine aims at slowing, arresting, and reversing phenomena associated with ageing by merging biotechnological innovation and engineered solutions. Ideally, by means of the newest medical technology, the "body machinery" should be kept fit and at peak performance all life long. Early detection of age-related dysfunction should thus be "fixed" at any age with interventions such as metabolic fine tuning, enhancement, regeneration, restoration or replacement of "body parts" (i.e. organs, skin, bone or muscle). It covers a vast array of domains: from cell therapy to pharmaceutical interventions, from bio-surgery to aesthetic surgery, from human enhancement to fortified food, from smart housing and robots to toxic-free environments. Anti-ageing medicine holds promises but also significant risks and safety issues which are addressesd in this book. It presents the latest scientific evidence on what works or does not work. It also provides public policy recommendations to ensure the protection of consumers and their rights while encouraging research and development. This book is intended for academics, health professionals, business persons, consumers and policy-makers interested in the latest evidence and ethical issues about anti-ageing medicine. |
Dentro del libro
Resultados 1-5 de 14
Página v
... ............... 5.3. Cell-Based Therapies: Stem Cells........................................................... 89 91 5.4. Gene Therapy, Genomics, Proteomics and Predictive Medicine.......... 101 5.4.1. Gene Therapy and Longevity ....
... ............... 5.3. Cell-Based Therapies: Stem Cells........................................................... 89 91 5.4. Gene Therapy, Genomics, Proteomics and Predictive Medicine.......... 101 5.4.1. Gene Therapy and Longevity ....
Página vi
Myths and Chances Astrid Stuckelberger. 5.4.1. Gene Therapy and Longevity ............................................................................ 101 Table 6: Genes Influencing Life Expectancy in 5.4 ...
Myths and Chances Astrid Stuckelberger. 5.4.1. Gene Therapy and Longevity ............................................................................ 101 Table 6: Genes Influencing Life Expectancy in 5.4 ...
Página 97
... therapy following patient request. In view of the promising therapeutic development, increasing collaboration and ... Gene-clinic Anti-Ageing Medicine 97.
... therapy following patient request. In view of the promising therapeutic development, increasing collaboration and ... Gene-clinic Anti-Ageing Medicine 97.
Página 100
... therapy ! The ethical debate should also focus on accessibility and affordability of regenerative medicine for all ... Gene Therapy , Genomics , Proteomics and Predictive 100 Anti - Ageing Medicine : Myths and Chances.
... therapy ! The ethical debate should also focus on accessibility and affordability of regenerative medicine for all ... Gene Therapy , Genomics , Proteomics and Predictive 100 Anti - Ageing Medicine : Myths and Chances.
Página 101
Myths and Chances Astrid Stuckelberger. 5.4 . Gene Therapy , Genomics , Proteomics and Predictive Medicine Background : Although gene therapy research started clinical trials in the 1990s already , it is still at an experimental stage ...
Myths and Chances Astrid Stuckelberger. 5.4 . Gene Therapy , Genomics , Proteomics and Predictive Medicine Background : Although gene therapy research started clinical trials in the 1990s already , it is still at an experimental stage ...
Términos y frases comunes
AAM market AAM products acid age-related ageing process Alzheimer’s disease anti-ageing interventions anti-ageing medicine anti-ageing research antioxidant benefits better ageing biogerontologists biological biomarkers body Botox botulinum toxin brain cancer centenarians chelation therapy clinical cognitive consumers cosmetic decline devices DHEA dietary supplements disability disease effects elderly enhancement ethical evidence expectancy function gene therapy genes genetic genomics geriatric groups healthy ageing human improve increase individual issues lifestyle live longevity maximum life span mental health mesotherapy metabolic muscle nutrition old age older persons patients perspective physical activity population potential practice practitioners prevention problems process of ageing programme promotion recommendations reliability theory risk factors robots scientific scientists social society specific statins stem cell strategies Stuckelberger studies successful ageing surgery Swiss Switzerland TA-SWISS testing testosterone Theory of Ageing therapy tissue treatment vitamin vitamin E women